Copyright
©The Author(s) 2015.
World J Gastrointest Pharmacol Ther. Nov 6, 2015; 6(4): 156-171
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.156
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.156
Figure 1 Inflammatory bowel disease drug metabolism considerations in pregnancy.
LMW: Low molecular weight.
Figure 2 Treatment approach strategy.
IBD: Inflammatory bowel disease.
- Citation: Hosseini-Carroll P, Mutyala M, Seth A, Nageeb S, Soliman D, Boktor M, Sheth A, Chapman J, Morris J, Jordan P, Manas K, Becker F, Alexander JS. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management. World J Gastrointest Pharmacol Ther 2015; 6(4): 156-171
- URL: https://www.wjgnet.com/2150-5349/full/v6/i4/156.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v6.i4.156